Fundraising Fox
Lisata Therapeutics, Inc.
NASDAQ: LSTA1 known investors
Find your way into Lisata Therapeutics, Inc.
Sign up to see every warm intro you have to Lisata Therapeutics, Inc.
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Lisata Therapeutics, Inc. team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Lisata develops drug delivery platform technology and therapies for solid tumors, enabling targeted anti-cancer drug delivery and immune system activation against cancer.
Founders & leadership
DJ
David J. MazzoPresident and Chief Executive Officer, Member of the Board of Directors at Lisata TherapeuticsDavid J. Mazzo holds a Ph.D. in Analytical Chemistry from the University of Massachusetts, Amherst, and has spent over four decades in pharmaceutical executive roles at companies including Schering-Plough Research Institute, Hoechst Marion Roussel, Rhone-Poulenc Rorer, Chugai Pharma USA, Æterna Zentaris, and Regado Biosciences. He is President and Chief Executive Officer of Lisata Therapeutics, a NASDAQ-listed company developing drug delivery technology for solid tumors.
KK
Kristen K. BuckChief Medical Officer and EVP, Head of R&D at Lisata Therapeutics (formerly Caladrius)Board-certified internal medicine physician with over 20 years of drug development and clinical experience, including roles as medical officer at the FDA, chief medical officer at multiple biotechnology and medical device companies, and leadership of clinical development and regulatory affairs functions across oncology, cardiovascular, and other therapeutic areas.
JN
James NiscoSenior Vice President, Finance and Treasury and Chief Accounting OfficerJames Nisco is Senior Vice President of Finance and Treasury and Chief Accounting Officer at Lisata Therapeutics, a company developing drug delivery platform technology for targeted cancer therapies. He has held finance and accounting roles across companies of various sizes, with expertise in SEC reporting, financial planning, and treasury operations.
Investors · 1
Related companies · 3
American Cancer Society (ACS)The American Cancer Society is a nonprofit organization that provides cancer research updates, screening and prevention guidance, and community engagement opportunities. It serves individuals seeking cancer information and those who want to support cancer research and patient advocacy efforts.
CancerresearchukCancer Research UK funds research across discovery, detection, prevention and treatment of cancer to improve patient outcomes and extend survival. It operates as a research funder and scientific organization serving academic and clinical researchers.
MD Anderson Cancer CenterUT MD Anderson is a cancer research and treatment center that provides patient care, conducts research, and offers education in cancer prevention and treatment. It is part of the University of Texas System and operates as a nonprofit medical institution.
Companies working in the same space as Lisata Therapeutics, Inc..
In the news
Frequently asked questions
- What does Lisata Therapeutics, Inc. do?
- Lisata develops drug delivery platform technology and therapies for solid tumors, enabling targeted anti-cancer drug delivery and immune system activation against cancer.
- Who are Lisata Therapeutics, Inc.'s investors?
- Lisata Therapeutics, Inc.'s investors include Kyoto University Innovation Capital.